Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight
06 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight Tetanus is a serious bacterial infection caused by Clostridium...
Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight
05 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight The growing demand for alopecia treatments is...
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight
04 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight The rising prevalence of urticaria...
Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight
31 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight The plasma protein therapeutics market is...
Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight
30 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight Sensorineural...
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight
29 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight The exosome market is fueled by several significant factors,...
Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight
28 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight ...
Global Anti-Aging Products Market is Projected to Cross ~USD 112 Billion by 2030 | DelveInsight
24 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Global Anti-Aging Products Market is Projected to Cross ~USD 112 Billion by 2030 | DelveInsight The rising demand for anti-aging products is...
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight
23 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight The dynamics of the...
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
22 oct. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The gene therapies...